← Back to SPRY

ARS Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 13/08/2025Mar 2024Filed 14/05/2025
$34$23$33$16$8$2.1$0.5$0
−$62−$61−$51−$45−$34−$19−$13−$10
−$0.63−$0.61−$0.52−$0.46−$0.35−$0.20−$0.13−$0.11
9999999898979796

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.